Related Experiment Video
Updated: Feb 8, 2026

07:43
Porcine As a Training Module for Head and Neck Microvascular Reconstruction
Published on: September 29, 2018
8.2K
Combating head and neck cancer metastases by targeting Src using multifunctional nanoparticle-based saracatinib
Liwei Lang1, Chloe Shay2, Yuanping Xiong1
1Department of Oral Biology, Dental College of Georgia, Augusta University, Augusta, GA, USA.
Journal of Hematology & Oncology
|June 22, 2018
Summary
Targeting Src kinase with saracatinib effectively inhibits head and neck squamous cell carcinoma (HNSCC) metastasis. Nanoparticle delivery of saracatinib enhances efficacy, offering a promising nanomedicine approach for HNSCC treatment.
Area of Science:
- Oncology
- Nanomedicine
- Molecular Biology
Background:
- Metastasis in head and neck squamous cell carcinoma (HNSCC) presents a significant therapeutic challenge.
- Src tyrosine kinase is a key driver of HNSCC progression and metastasis.
- Current Src-targeted therapies for HNSCC face limitations in delivery and mechanistic understanding.
Purpose of the Study:
- To investigate the efficacy of Src inhibition using saracatinib in HNSCC metastasis.
- To elucidate the molecular mechanisms underlying saracatinib's anti-metastatic effects.
- To develop and evaluate a nanoparticle-based drug delivery system for enhanced saracatinib therapy.
Main Methods:
- Src knockdown was established using lentiviral vectors.
- Cell migration and invasion were assessed via wound healing and Transwell assays.
- Saracatinib was encapsulated in self-assembling nanoparticles; efficacy was tested in a mouse metastasis model.
Main Results:
- Saracatinib effectively suppressed HNSCC invasion and metastasis by downregulating Vimentin and Snail.
- Nanoparticle-formulated saracatinib demonstrated superior anti-metastatic effects compared to the free drug in vivo.
- Enhanced efficacy is attributed to a targeted nanoparticle delivery system.
Conclusions:
- Src inhibition with saracatinib is a viable strategy against HNSCC metastasis.
- Nanoparticle-mediated delivery of saracatinib represents a promising nanomedicine approach.
- This study advances the development of targeted therapies for metastatic HNSCC.
Related Concept Videos
Arteries of the Head and Neck
3.3K
The human body's intricate network of arteries ensures that every organ system receives the necessary oxygen and nutrients for optimal function. The arterial network in the head and neck region is particularly complex, providing vital blood flow to the brain, eyes, and other critical structures. Prominent arteries in this region include the internal carotid arteries and the vertebral arteries.
The internal carotid arteries supply blood to the anterior portion of the cerebrum. They enter the...
The internal carotid arteries supply blood to the anterior portion of the cerebrum. They enter the...
3.3K
Veins of Head and Neck
5.7K
The blood drainage from the head and neck is primarily managed by three pairs of veins: the external jugular, internal jugular, and vertebral veins. The external jugular veins drain superficial scalp and face structures, passing over the sternocleidomastoid muscles to empty into the subclavian veins.
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
5.7K
Targeted Cancer Therapies
8.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.9K
Muscles of the Anterior Neck
4.8K
The anterior neck muscles are the group of muscles covering the front part of the neck. These muscles are classified into three subgroups. The first one is the superficial muscles, the most visible muscles in the front of the neck. It includes the platysma and sternocleidomastoid. The second group is the suprahyoid muscles, located above the hyoid bone. This group comprises the digastric, mylohyoid, geniohyoid, and stylohyoid. Lastly, the infrahyoid muscles are found below the hyoid bone and...
4.8K
Muscles that Move the Head
6.0K
The muscles that move the head are a dynamic and complex group of structures that work together to facilitate a wide range of head movements, including rotation, flexion, extension, and lateral bending.
The bilateral sternocleidomastoid, or SCM, and the suprahyoid and infrahyoid muscles are significant head flexors. The SCM muscles originate at the sternum and clavicle and attach to the mastoid process of the temporal bone. The SCM contracts bilaterally to bend the head forward, whereas...
The bilateral sternocleidomastoid, or SCM, and the suprahyoid and infrahyoid muscles are significant head flexors. The SCM muscles originate at the sternum and clavicle and attach to the mastoid process of the temporal bone. The SCM contracts bilaterally to bend the head forward, whereas...
6.0K
Cancer
54.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
54.4K

